Skip to main content
Top
Published in: BMC Cancer 1/2003

Open Access 01-12-2003 | Research article

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data

Authors: Marc E Lenburg, Louis S Liou, Norman P Gerry, Garrett M Frampton, Herbert T Cohen, Michael F Christman

Published in: BMC Cancer | Issue 1/2003

Login to get access

Abstract

Background

Renal cell carcinoma is a common malignancy that often presents as a metastatic-disease for which there are no effective treatments. To gain insights into the mechanism of renal cell carcinogenesis, a number of genome-wide expression profiling studies have been performed. Surprisingly, there is very poor agreement among these studies as to which genes are differentially regulated. To better understand this lack of agreement we profiled renal cell tumor gene expression using genome-wide microarrays (45,000 probe sets) and compare our analysis to previous microarray studies.

Methods

We hybridized total RNA isolated from renal cell tumors and adjacent normal tissue to Affymetrix U133A and U133B arrays. We removed samples with technical defects and removed probesets that failed to exhibit sequence-specific hybridization in any of the samples. We detected differential gene expression in the resulting dataset with parametric methods and identified keywords that are overrepresented in the differentially expressed genes with the Fisher-exact test.

Results

We identify 1,234 genes that are more than three-fold changed in renal tumors by t-test, 800 of which have not been previously reported to be altered in renal cell tumors. Of the only 37 genes that have been identified as being differentially expressed in three or more of five previous microarray studies of renal tumor gene expression, our analysis finds 33 of these genes (89%). A key to the sensitivity and power of our analysis is filtering out defective samples and genes that are not reliably detected.

Conclusions

The widespread use of sample-wise voting schemes for detecting differential expression that do not control for false positives likely account for the poor overlap among previous studies. Among the many genes we identified using parametric methods that were not previously reported as being differentially expressed in renal cell tumors are several oncogenes and tumor suppressor genes that likely play important roles in renal cell carcinogenesis. This highlights the need for rigorous statistical approaches in microarray studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin. 2003, 53: 5-26.CrossRefPubMed Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin. 2003, 53: 5-26.CrossRefPubMed
2.
go back to reference Gnarra JR, Lerman MI, Zbar B, Linehan WM: Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol. 1995, 22: 3-8.PubMed Gnarra JR, Lerman MI, Zbar B, Linehan WM: Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol. 1995, 22: 3-8.PubMed
3.
go back to reference Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H: Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res. 2000, 60: 6503-6509.PubMed Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H: Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res. 2000, 60: 6503-6509.PubMed
4.
go back to reference Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z: Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol. 1996, 149: 2089-2094.PubMedPubMedCentral Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z: Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am J Pathol. 1996, 149: 2089-2094.PubMedPubMedCentral
5.
go back to reference Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999, 399: 271-275. 10.1038/20459.CrossRefPubMed Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999, 399: 271-275. 10.1038/20459.CrossRefPubMed
7.
go back to reference Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral
10.
go back to reference Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA: NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res. 2003, 31: 82-86. 10.1093/nar/gkg121.CrossRefPubMedPubMedCentral Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA: NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res. 2003, 31: 82-86. 10.1093/nar/gkg121.CrossRefPubMedPubMedCentral
11.
go back to reference Benjamini Y, Hochberg Y: Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met. 1995, 57: 289-300. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met. 1995, 57: 289-300.
12.
go back to reference Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001, 158: 1639-1651.CrossRefPubMedPubMedCentral Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS: Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001, 158: 1639-1651.CrossRefPubMedPubMedCentral
13.
go back to reference Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD: Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003, 162: 925-932.CrossRefPubMedPubMedCentral Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD: Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003, 162: 925-932.CrossRefPubMedPubMedCentral
14.
go back to reference Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A. 2001, 98: 9754-9759. 10.1073/pnas.171209998.CrossRefPubMedPubMedCentral Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, Haab BB, Teh BT: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A. 2001, 98: 9754-9759. 10.1073/pnas.171209998.CrossRefPubMedPubMedCentral
15.
go back to reference Gieseg MA, Cody T, Man MZ, Madore SJ, Rubin MA, Kaldjian EP: Expression profiling of human renal carcinomas with functional taxonomic analysis. BMC Bioinformatics. 2002, 3: 26-10.1186/1471-2105-3-26.CrossRefPubMedPubMedCentral Gieseg MA, Cody T, Man MZ, Madore SJ, Rubin MA, Kaldjian EP: Expression profiling of human renal carcinomas with functional taxonomic analysis. BMC Bioinformatics. 2002, 3: 26-10.1186/1471-2105-3-26.CrossRefPubMedPubMedCentral
16.
go back to reference Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, Haas S, Korn B, Gunawan B, Vente A, Fuzesi L, Vingron M, Poustka A: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 2001, 11: 1861-1870.PubMedPubMedCentral Boer JM, Huber WK, Sultmann H, Wilmer F, von Heydebreck A, Haas S, Korn B, Gunawan B, Vente A, Fuzesi L, Vingron M, Poustka A: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 2001, 11: 1861-1870.PubMedPubMedCentral
17.
go back to reference Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA: SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 2003, 31: 219-223. 10.1093/nar/gkg014.CrossRefPubMedPubMedCentral Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA: SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 2003, 31: 219-223. 10.1093/nar/gkg014.CrossRefPubMedPubMedCentral
18.
go back to reference Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 1999, 154: 981-986.CrossRefPubMedPubMedCentral Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP, Sauter G: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol. 1999, 154: 981-986.CrossRefPubMedPubMedCentral
19.
go back to reference Skubitz KM, Skubitz AP: Differential gene expression in renal-cell cancer. J Lab Clin Med. 2002, 140: 52-64. 10.1067/mlc.2002.125213.CrossRefPubMed Skubitz KM, Skubitz AP: Differential gene expression in renal-cell cancer. J Lab Clin Med. 2002, 140: 52-64. 10.1067/mlc.2002.125213.CrossRefPubMed
20.
go back to reference Hodges PE, Carrico PM, Hogan JD, O'Neill KE, Owen JJ, Mangan M, Davis BP, Brooks JE, Garrels JI: Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 2002, 30: 137-141. 10.1093/nar/30.1.137.CrossRefPubMedPubMedCentral Hodges PE, Carrico PM, Hogan JD, O'Neill KE, Owen JJ, Mangan M, Davis BP, Brooks JE, Garrels JI: Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 2002, 30: 137-141. 10.1093/nar/30.1.137.CrossRefPubMedPubMedCentral
21.
go back to reference Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P: Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci. 2002, 43: 2767-2773.PubMed Eichler W, Friedrichs U, Thies A, Tratz C, Wiedemann P: Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest Ophthalmol Vis Sci. 2002, 43: 2767-2773.PubMed
22.
go back to reference Lee TH, Klampfer L, Shows TB, Vilcek J: Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. J Biol Chem. 1993, 268: 6154-6160.PubMed Lee TH, Klampfer L, Shows TB, Vilcek J: Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. J Biol Chem. 1993, 268: 6154-6160.PubMed
23.
go back to reference Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M: Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab. 2002, 87: 2399-10.1210/jc.87.5.2399.CrossRefPubMed Ringel MD, Hardy E, Bernet VJ, Burch HB, Schuppert F, Burman KD, Saji M: Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab. 2002, 87: 2399-10.1210/jc.87.5.2399.CrossRefPubMed
24.
go back to reference Wang Y, Simonson MS, Pouyssegur J, Dunn MJ: Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells. Biochem J. 1992, 287 ( Pt 2): 589-594.CrossRef Wang Y, Simonson MS, Pouyssegur J, Dunn MJ: Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells. Biochem J. 1992, 287 ( Pt 2): 589-594.CrossRef
25.
go back to reference Salani D, Di Castro V, Nicotra MR, Rosano L, Tecce R, Venuti A, Natali PG, Bagnato A: Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol. 2000, 157: 1537-1547.CrossRefPubMedPubMedCentral Salani D, Di Castro V, Nicotra MR, Rosano L, Tecce R, Venuti A, Natali PG, Bagnato A: Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol. 2000, 157: 1537-1547.CrossRefPubMedPubMedCentral
26.
go back to reference Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A: Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000, 157: 1703-1711.CrossRefPubMedPubMedCentral Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A: Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000, 157: 1703-1711.CrossRefPubMedPubMedCentral
27.
go back to reference Harris AL: Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed Harris AL: Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed
28.
go back to reference Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A: Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem. 2002, 277: 27850-27855. 10.1074/jbc.M202421200.CrossRefPubMed Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A: Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem. 2002, 277: 27850-27855. 10.1074/jbc.M202421200.CrossRefPubMed
29.
go back to reference Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001, 107: 43-54.CrossRefPubMed Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001, 107: 43-54.CrossRefPubMed
30.
go back to reference Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001, 93: 1337-1343. 10.1093/jnci/93.17.1337.CrossRefPubMed Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001, 93: 1337-1343. 10.1093/jnci/93.17.1337.CrossRefPubMed
31.
go back to reference Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, Adema GJ, Oosterwijk E: Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer. 2000, 85: 865-870. 10.1002/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q.CrossRefPubMed Grabmaier K, Vissers JL, De Weijert MC, Oosterwijk-Wakka JC, Van Bokhoven A, Brakenhoff RH, Noessner E, Mulders PA, Merkx G, Figdor CG, Adema GJ, Oosterwijk E: Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer. 2000, 85: 865-870. 10.1002/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q.CrossRefPubMed
32.
go back to reference Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, Force T, Nishiyama J: Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J Biol Chem. 2001, 276: 18702-18709. 10.1074/jbc.M011774200.CrossRefPubMedPubMedCentral Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, Force T, Nishiyama J: Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J Biol Chem. 2001, 276: 18702-18709. 10.1074/jbc.M011774200.CrossRefPubMedPubMedCentral
33.
go back to reference Hirani N, Antonicelli F, Strieter RM, Wiesener MS, Ratcliffe PJ, Haslett C, Donnelly SC: The regulation of interleukin-8 by hypoxia in human macrophages--a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med. 2001, 7: 685-697.PubMedPubMedCentral Hirani N, Antonicelli F, Strieter RM, Wiesener MS, Ratcliffe PJ, Haslett C, Donnelly SC: The regulation of interleukin-8 by hypoxia in human macrophages--a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med. 2001, 7: 685-697.PubMedPubMedCentral
34.
go back to reference Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A: Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res. 2000, 6: 480-487.PubMed Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A: Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res. 2000, 6: 480-487.PubMed
35.
go back to reference Dougherty C, Barucha J, Schofield PR, Jacobson KA, Liang BT: Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor. Faseb J. 1998, 12: 1785-1792.PubMed Dougherty C, Barucha J, Schofield PR, Jacobson KA, Liang BT: Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor. Faseb J. 1998, 12: 1785-1792.PubMed
36.
go back to reference O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R., 3rd, Le Beau MM, Earp HS, Liu ET: axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991, 11: 5016-5031.CrossRefPubMedPubMedCentral O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R., 3rd, Le Beau MM, Earp HS, Liu ET: axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991, 11: 5016-5031.CrossRefPubMedPubMedCentral
37.
go back to reference Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL: Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A. 1995, 92: 8483-8487.CrossRefPubMedPubMedCentral Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL: Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A. 1995, 92: 8483-8487.CrossRefPubMedPubMedCentral
38.
go back to reference Harris RS, Petersen-Mahrt SK, Neuberger MS: RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell. 2002, 10: 1247-1253.CrossRefPubMed Harris RS, Petersen-Mahrt SK, Neuberger MS: RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell. 2002, 10: 1247-1253.CrossRefPubMed
39.
go back to reference Kim JK, Ryll R, Ishizuka Y, Kato S: Identification of cDNAs encoding two novel nuclear proteins, IMUP-1 and IMUP-2, upregulated in SV40-immortalized human fibroblasts. Gene. 2000, 257: 327-334. 10.1016/S0378-1119(00)00414-5.CrossRefPubMed Kim JK, Ryll R, Ishizuka Y, Kato S: Identification of cDNAs encoding two novel nuclear proteins, IMUP-1 and IMUP-2, upregulated in SV40-immortalized human fibroblasts. Gene. 2000, 257: 327-334. 10.1016/S0378-1119(00)00414-5.CrossRefPubMed
40.
go back to reference Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB: ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996, 271: 20458-20464. 10.1074/jbc.271.34.20458.CrossRefPubMed Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB: ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996, 271: 20458-20464. 10.1074/jbc.271.34.20458.CrossRefPubMed
41.
go back to reference Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y: Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res. 1999, 59: 1966-1972.PubMed Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y: Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res. 1999, 59: 1966-1972.PubMed
42.
go back to reference Del Sal G, Collavin L, Ruaro ME, Edomi P, Saccone S, Valle GD, Schneider C: Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene. Proc Natl Acad Sci U S A. 1994, 91: 1848-1852.CrossRefPubMedPubMedCentral Del Sal G, Collavin L, Ruaro ME, Edomi P, Saccone S, Valle GD, Schneider C: Structure, function, and chromosome mapping of the growth-suppressing human homologue of the murine gas1 gene. Proc Natl Acad Sci U S A. 1994, 91: 1848-1852.CrossRefPubMedPubMedCentral
43.
go back to reference Evdokiou A, Cowled PA: Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines. Int J Cancer. 1998, 75: 568-577. 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.3.CO;2-O.CrossRefPubMed Evdokiou A, Cowled PA: Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines. Int J Cancer. 1998, 75: 568-577. 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.3.CO;2-O.CrossRefPubMed
44.
go back to reference Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, Porter CW: Effects of conditional overexpression of spermidine/spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem. 2000, 275: 38319-38328. 10.1074/jbc.M003270200.CrossRefPubMed Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, Porter CW: Effects of conditional overexpression of spermidine/spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem. 2000, 275: 38319-38328. 10.1074/jbc.M003270200.CrossRefPubMed
45.
go back to reference Rogers MS, Kobayashi T, Pittelkow MR, Strehler EE: Human calmodulin-like protein is an epithelial-specific protein regulated during keratinocyte differentiation. Exp Cell Res. 2001, 267: 216-224. 10.1006/excr.2001.5254.CrossRefPubMed Rogers MS, Kobayashi T, Pittelkow MR, Strehler EE: Human calmodulin-like protein is an epithelial-specific protein regulated during keratinocyte differentiation. Exp Cell Res. 2001, 267: 216-224. 10.1006/excr.2001.5254.CrossRefPubMed
46.
go back to reference Schraml P, Shipman R, Colombi M, Ludwig CU: Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue. Cancer Res. 1994, 54: 5236-5240.PubMed Schraml P, Shipman R, Colombi M, Ludwig CU: Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue. Cancer Res. 1994, 54: 5236-5240.PubMed
47.
go back to reference Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace A. J., Jr.: Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 1999, 18: 2892-2900. 10.1038/sj.onc.1202667.CrossRefPubMed Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace A. J., Jr.: Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 1999, 18: 2892-2900. 10.1038/sj.onc.1202667.CrossRefPubMed
48.
go back to reference Nakagawa J, Waldner H, Meyer-Monard S, Hofsteenge J, Jeno P, Moroni C: AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci U S A. 1995, 92: 2051-2055.CrossRefPubMedPubMedCentral Nakagawa J, Waldner H, Meyer-Monard S, Hofsteenge J, Jeno P, Moroni C: AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc Natl Acad Sci U S A. 1995, 92: 2051-2055.CrossRefPubMedPubMedCentral
49.
go back to reference Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A, Schafer R: The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene. 2002, 21: 2829-2839. 10.1038/sj.onc.1205377.CrossRefPubMed Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A, Schafer R: The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene. 2002, 21: 2829-2839. 10.1038/sj.onc.1205377.CrossRefPubMed
50.
go back to reference Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast R. C., Jr.: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A. 1999, 96: 214-219. 10.1073/pnas.96.1.214.CrossRefPubMedPubMedCentral Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast R. C., Jr.: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A. 1999, 96: 214-219. 10.1073/pnas.96.1.214.CrossRefPubMedPubMedCentral
51.
go back to reference Reiss J: Genetics of molybdenum cofactor deficiency. Hum Genet. 2000, 106: 157-163. 10.1007/s004390051023.CrossRefPubMed Reiss J: Genetics of molybdenum cofactor deficiency. Hum Genet. 2000, 106: 157-163. 10.1007/s004390051023.CrossRefPubMed
52.
go back to reference Reiss J, Cohen N, Dorche C, Mandel H, Mendel RR, Stallmeyer B, Zabot MT, Dierks T: Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet. 1998, 20: 51-53. 10.1038/1706.CrossRefPubMed Reiss J, Cohen N, Dorche C, Mandel H, Mendel RR, Stallmeyer B, Zabot MT, Dierks T: Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet. 1998, 20: 51-53. 10.1038/1706.CrossRefPubMed
53.
go back to reference Feng G, Tintrup H, Kirsch J, Nichol MC, Kuhse J, Betz H, Sanes JR: Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science. 1998, 282: 1321-1324. 10.1126/science.282.5392.1321.CrossRefPubMed Feng G, Tintrup H, Kirsch J, Nichol MC, Kuhse J, Betz H, Sanes JR: Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science. 1998, 282: 1321-1324. 10.1126/science.282.5392.1321.CrossRefPubMed
Metadata
Title
Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
Authors
Marc E Lenburg
Louis S Liou
Norman P Gerry
Garrett M Frampton
Herbert T Cohen
Michael F Christman
Publication date
01-12-2003
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2003
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-3-31

Other articles of this Issue 1/2003

BMC Cancer 1/2003 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine